Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Armistice Capital, Llc
Form 13F · Q2 2026

Armistice Capital, Llc

CIK 1601086Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$8.2B
Reported book value
341
Positions
12
Quarters on record
Top 50
Positions

Armistice Capital, Llc — holdings

Top 50 positions of 341, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1MDGL Madrigal Pharmaceuticals Inc288,000+8.9%$155M1.9%
2SUPN Supernus Pharmaceuticals2.6M+39.6%$123M1.5%
3CYTK Cytokinetics Inc1.2M+57.1%$102M1.3%
4INCY Incyte Corp900,005+37.0%$102M1.2%
5NBIX Neurocrine Biosciences Inc535,838−26.0%$90M1.1%
6TVTX Travere Therapeutics Inc1.6M−67.9%$89M1.1%
7AGIO Agios Pharmaceuticals Inc2.4M−11.6%$89M1.1%
8PTCT Ptc Therapeutics Inc1.1M−48.4%$87M1.1%
9UNH Unitedhealth Group Inc183,000+23.6%$76M0.9%
10FRPT Freshpet Inc1.3M+15.3%$75M0.9%
11DYN Dyne Therapeutics Inc3.1M−2.8%$69M0.8%
12AMZN Amazon Com Inc284,562+8.6%$68M0.8%
13IMVT Immunovant Inc1.7M−51.3%$67M0.8%
14RIGL Rigel Pharmaceuticals Inc1.7M+30.6%$65M0.8%
15TMO Thermo Fisher Scientific Inc122,480+33.9%$61M0.8%
16IRWD Ironwood Pharmaceuticals Inc13.9M−7.3%$59M0.7%
17HRMY Harmony Biosciences Hldgs In1.6M−3.7%$57M0.7%
18REGN Regeneron Pharmaceuticals89,809+148.6%$56M0.7%
19NKTR Nektar Therapeutics724,000+25.3%$51M0.6%
20MLYS Mineralys Therapeutics Inc1.7M+47.6%$47M0.6%
21SNY Sanofi Sa1.1M+254.7%$45M0.6%
22IMCR Immunocore Hldgs Plc1.4M+20.2%$45M0.6%
23GOOGL Alphabet Inc126,494+6.7%$45M0.6%
24SLDB Solid Biosciences Inc4.3M+33.7%$43M0.5%
25MDB Mongodb Inc125,172+16.7%$42M0.5%
26KURA Kura Oncology Inc3.7M−1.6%$40M0.5%
27XRAY Dentsply Sirona Inc3.7M+22.4%$39M0.5%
28UBER Uber Technologies Inc497,908−4.0%$36M0.4%
29AXGN Axogen Inc775,000−17.2%$36M0.4%
30IRON Disc Medicine Inc460,000−14.2%$34M0.4%
31GTLB Gitlab Inc1.1M+4.4%$33M0.4%
32FIVN Five9 Inc1.5M−3.5%$33M0.4%
33HUBS Hubspot Inc178,047+38.5%$32M0.4%
34ALGN Align Technology Inc180,286+14.1%$30M0.4%
35MSFT Microsoft Corp80,581+64.9%$30M0.4%
36OFIX Orthofix Med Inc3.3M+20.9%$30M0.4%
37HUM Humana Inc72,527−48.7%$29M0.4%
38ANGO Angiodynamics Inc2.2M+17.6%$29M0.3%
39WATERS CORP Waters Corp75,004—$28M0.3%
40VSTM Verastem Inc7.0M+53.0%$27M0.3%
41FDMT 4D Molecular Therapeutics In2.0M+0.0%$27M0.3%
42NTLA Intellia Therapeutics Inc1.5M+346.4%$25M0.3%
43WYNN Wynn Resorts Ltd261,065+50.4%$25M0.3%
44TREACE MED CONCEPTS INC Treace Med Concepts Inc6.4M+0.0%$25M0.3%
45AUTL Autolus Therapeutics Ltd15.0M−5.1%$24M0.3%
46ARVN Arvinas Inc2.8M+41.4%$23M0.3%
47MGNX Macrogenics Inc5.0M−16.7%$23M0.3%
48ANRO Alto Neuroscience Inc864,000−5.3%$23M0.3%
49TOST Toast Inc810,830+40.4%$23M0.3%
50PATH Uipath Inc2.0M+55.7%$22M0.3%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.